Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Cephalon drug may treat MS fatigue

A nine-week 72-patient U.S. trial of CEPH's Provigil

Read the full 83 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE